Molekule Group (Molekule Group) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Molekule Group is: No Data: Cannot be evaluated.

Competitive Comparison of Molekule Group's Risk Assessment

For the Pollution & Treatment Controls subindustry, Molekule Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Molekule Group's Risk Assessment Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Molekule Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Molekule Group's Risk Assessment falls into.

Molekule Group (OTCPK:MKULQ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Molekule Group Risk Assessment Related Terms

Thank you for viewing the detailed overview of Molekule Group's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Molekule Group (Molekule Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410

Website

https://www.molekule.com

Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.

Executives

Ritankar Pal	officer: Chief Operating Officer	10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410
Jonathan Harris	officer: Chief Commercial Officer	3000 CLEARVIEW WAY, SAN MATEO CA 94402
Bradley A Feld	director	C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302
Ryan A Mcintyre	10 percent owner
Seth Levine	10 percent owner	1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Fg Next Gp, Llc	10 percent owner	1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Foundry Group Next, L.p.	10 percent owner	C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302
Ward Jr Stephen M	director	C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612
Timothy J Scannell	director	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Heather Floyd	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Thomas P Mccaffrey	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Lewis C Pell	10 percent owner	C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760
Michael F Senft	director	1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Jason Dibona	officer: Chief Executive Officer	10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410
David Helfet	director	10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410